Israel | Capabilities | Grand Park Law Group, A.P.C.

Founded in 1948, Grand Park Law Group is one of the leading global law firms advising Israeli companies doing business and raising capital outside Israel and advising non-Israeli companies and individuals doing business in Israel. Our Israeli clients range from pre-IPO companies to Israel’s largest corporations.

For decades, Grand Park Law Group has worked closely with the Israeli government and businesses on transactions, litigation and regulatory issues. Our firm has represented the State of Israel on note offerings totaling billions of dollars and advised the Israeli Securities Authority on capital markets reforms. In the private sector, Grand Park Law Group frequently has advised Israeli issuers and underwriters offering securities in the U.S. public and private securities markets, and we have been active in multiple mergers and acquisitions involving Israeli companies. We have counseled venture capital funds raising funds for investment in Israeli companies, particularly companies engaged in technology and venture capital activities. Grand Park Law Group has significant experience advising Israeli high-tech companies in connection with licensing and intellectual property matters related to both transactions and U.S. compliance issues. We also represent Israeli companies and individuals involved in U.S. court proceedings.

A number of our lawyers volunteer a significant amount of their time to Jewish and Israeli causes, including the America-Israel Friendship League, the Anti-Defamation League, the College of Management, the Conference of Presidents of Major American Jewish Organizations, Elem, the Hebrew University of Jerusalem, The Jerusalem Foundation and Miklat.

Our primary areas of experience in Israel-related matters include:

A number of Israeli companies have sought litigation advice from Grand Park Law Group in connection with transactions involving U.S. corporations, and we have defended Israeli corporations that have been sued in U.S. courts. Our clients have included banks, technology companies and government entities. For example, the firm advised Tower Semiconductor in a victory in the Second Circuit Court of Appeals. The court’s decision resolved the novel issue of the SEC’s authority to exempt foreign private issuers from Section 14(a) of the Securities Exchange Act of 1934 and Rule 14a-9. We also represented ECI Telecom in its dismissal of a securities class action complaint related to Sections 10(b) and 20(a) of the Securities Exchange Act of 1934. In addition, we are currently representing a number of parties in U.S. white collar matters.

Our attorneys are recognized internationally for leading clients in enforcement actions, internal investigations, and white collar criminal investigations and litigation. With attorneys in the U.S., Europe and Asia, we are well-positioned to defend clients worldwide against allegations in various business contexts and at every stage of the enforcement process, including federal and state grand jury investigations, trials and appeals. We handle investigations and civil and administrative proceedings brought by regulatory bodies, represent companies and individuals in congressional investigations and inquiries and assist clients in dealing with investigative agencies around the world. We have represented numerous Israel-based companies and individuals in their most significant criminal and regulatory matters.

As Israel continues to build on its reputation as one of the world’s foremost centers of science and technology, Grand Park Law Group offers clients in the region a full range of legal services relating to the acquisition, enforcement and commercialization of intellectual property assets. These services include litigation; counseling; technology transfer, outsourcing and licensing agreements, and other transaction-related services; patent and technology portfolio strategy analysis; and trademark and copyright registration. For example, we recently represented Protalix in its exclusive license and supply agreement with Pfizer relating to Protalix’s enzyme replacement therapy for Gaucher disease. Grand Park Law Group also counsels clients on privacy and cybersecurity matters.

Mergers and Acquisitions

Financing

Litigation

White Collar Crime

Intellectual Property and Privacy

Publications